Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B‐cell chronic lymphocytic leukemia
暂无分享,去创建一个
H. Kantarjian | T. Manshouri | M. Keating | F. Giles | M. Albitar | Deborah A. Thomas | S. Ibrahim | S. Faderl | Hagop Kantarjian | Maher Albitar | Stefan Faderl | Taghi Manshouri | Michael Keating | Iman Jilani | Francis Giles | Sherif Ibrahim | Susan O'Brien | Anna Rogers | Deborah Thomas | I. Jilani | A. Rogers | S. O’Brien | S. O'Brien | D. Thomas | Anna Rogers
[1] A. Tefferi,et al. Analysis of clonal B‐cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B‐chronic lymphocytic leukaemia , 2001, British journal of haematology.
[2] J. McKenney,et al. CD31 Expression in Intratumoral Macrophages: A Potential Diagnostic Pitfall , 2001, The American journal of surgical pathology.
[3] K. Do,et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. , 2001, Blood.
[4] D. Jackson,et al. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is associated with a naïve B-cell phenotype in human tonsils. , 2000, Tissue antigens.
[5] T J Hamblin,et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.
[6] M. Chilosi,et al. Human myeloma cells express the CD38 ligand CD31 , 1999, British journal of haematology.
[7] Terry J. Hamblin,et al. Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia , 1999 .
[8] N. Chiorazzi,et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.
[9] K. Kliche,et al. Coexpression of CD40 and CD40 ligand in B‐cell lymphoma cells , 1998, British journal of haematology.
[10] E. Schattner,et al. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. , 1998, Blood.
[11] U. Dianzani,et al. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. , 1998, Journal of immunology.
[12] K Konstantopoulos,et al. Perspectives Series: Cell Adhesion in Vascular Biology Effects of Fluid Dynamic Forces on Vascular Cell Adhesion , 1996 .
[13] P. J. Newman,et al. The biology of PECAM-1. , 1997, The Journal of clinical investigation.
[14] S. Zupo,et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. , 1996, Blood.
[15] P. Newman,et al. Changes in expression of the cell adhesion molecule PECAM-1 (CD31) during differentiation of human leukemic cell lines. , 1994, Tissue antigens.
[16] A. Hatzfeld,et al. The heparin binding PECAM-1 adhesion molecule is expressed by CD34+ hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. , 1993, Blood.
[17] D. Phillips,et al. PECAM-1 is required for transendothelial migration of leukocytes , 1993, The Journal of experimental medicine.
[18] O. Majdic,et al. Molecular characterization and functional analysis of the leukocyte surface protein CD31. , 1990, Journal of immunology.
[19] C. Power,et al. Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen , 1990, The Journal of experimental medicine.
[20] L. Romer,et al. EndoCAM: a novel endothelial cell-cell adhesion molecule , 1990, The Journal of cell biology.
[21] J. Gorski,et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. , 1990, Science.